Associate Director / Director, Signatera Emerging Indications
NateraSalary not specified
- Full Time
- Senior (5 to 8 years)
$180,000 – $220,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Affairs, Pharmaceutical, Genetics, HealthcareIndustries
Position Overview
- Location Type: [Not Specified]
- Employment Type: Full time
- Reports To: Senior Medical Affairs Director for Oncology
Summary: Illumina, Inc. is seeking a board-certified molecular genetic pathologist with extensive leadership experience in molecular screening and diagnostic testing for cancer. This role will contribute to realizing health equity for billions of people around the world through genomic technology. The individual will be responsible for informing product development, patient safety risk assessments, regulatory submissions, guiding medical research, overseeing clinical diagnostics for companion diagnostics development, supporting biopharma collaborations, and participating in medical education. This role will work closely with cross-functional teams including Commercial, Business Development, Pharma, R&D, Product Marketing, Regulatory, Bioinformatics, Assay Development, and Quality teams.
Requirements
- Board-Certified Molecular Genetic Pathologist
- Extensive Leadership Experience in molecular screening and diagnostic testing for cancer
- Strong Background in molecular and cytogenetic methods used for cancer diagnostics (solid tumors and hematological malignancies), including:
- Complete genomic profiling of solid tumors
- Cell-free tumor DNA (liquid biopsy) analysis
- Minimal residual disease monitoring
- Hereditary cancer screening and diagnostics using germline next-generation sequencing
- Pharmacogenomics
- Understanding of trends in professional practice in molecular oncology in the United States
- Wide network of connections with key opinion leaders
- Intimate understanding of trends in next-generation sequencing, clinical laboratory practices, and their regulatory oversight.
- Demonstrated leadership in cancer research and publications contributing to advancing clinical management of individuals going through their cancer journeys.
Responsibilities
- Informing oncology-related product development
- Conducting patient safety risk assessments
- Supporting regulatory submissions
- Guiding medical research in oncology
- Overseeing clinical diagnostics for companion diagnostics development
- Supporting interactions with biopharma collaborations in oncology
- Participating in medical education in molecular screening and diagnostics for cancer
- Working closely with cross-functional teams (Commercial, Business Development, Pharma, R&D, Product Marketing, Regulatory, Bioinformatics, Assay Development, and Quality teams)
Salary:
- [Not Specified]
Skills
Next-Generation Sequencing
Molecular Screening
Diagnostic Testing
Cancer Diagnostics
Genomic Profiling
Cell-Free Tumor DNA Analysis
Germline Sequencing
Clinical Laboratory Practices
Regulatory Oversight
Medical Education
Risk Assessment
Biopharma Collaborations
Illumina
Supports genomics startups through funding and resources
About Illumina
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.
San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees